Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05863052 · ClinicalTrials.gov registry record
Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population
A clinical trial of Non-Small Cell Lung Cancer and Melanoma, sponsored by University of Oklahoma.
- Active
- Registry status
- 72
- Enrollment target
- 6
- Study locations
NCT05863052: Active study of Non-Small Cell Lung Cancer and Melanoma, sponsored by University of Oklahoma.
NCT05863052 is a study of Non-Small Cell Lung Cancer and Melanoma that is active but no longer recruiting, run by University of Oklahoma. The registered enrollment target is 72 participants, below the 652-participant average among 454 other Non-Small Cell Lung Cancer trials with a reported enrollment target (89% lower). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05863052, a study of Non-Small Cell Lung Cancer and Melanoma, is active but no longer recruiting, sponsored by University of Oklahoma.
- ACTIVE NOT RECRUITING
- Registry status
- 72 participants
- Enrollment target
- 6
- Study locations
Study Summary
The aim of this study is to describe the outcomes in American Indian patients receiving immunotherapy in a multi-institution retrospective study at several other high-volume centers that care for this patient population and to identify any healthcare disparities that can lead to future interventional studies.
Primary Outcome
Evaluating progression free survival of American Indian population vs. White population who were treated with immunotherapy
Conditions Studied
Interventions
- BIOLOGICAL Immunotherapy
Study Locations (6)
South Dakota
- Monument Health Cancer Care Institute - Rapid City
- Avera Cancer Institute - Sioux Falls
Arizona
- Arizona Cancer Center at the Unvieristy of Arizona - Tucson
New Mexico
- University of New Mexico Comprehensive Cancer Center - Albuquerque
Oklahoma
- Stephenson Cancer Center - Oklahoma City
Utah
- Huntsman Cancer Institute at the University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2022-01-31 |
| Est. Completion | 2027-12 |
What the registry record for NCT05863052 still lists
NCT05863052 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 652-participant average among 454 other Non-Small Cell Lung Cancer trials with a reported enrollment target (89% lower).
The record links to 7 conditions, with Non-Small Cell Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Immunotherapy is the first listed.
NCT05863052 lists 6 locations in 5 states (South Dakota, Arizona, New Mexico).
Frequently Asked Questions
What is clinical trial NCT05863052 about?
NCT05863052 is a clinical study titled "Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population". The aim of this study is to describe the outcomes in American Indian patients receiving immunotherapy in a multi-institution retrospective study at several other high-volume centers that care for this patient population and to identify any healthcare disparities that can lead to future interventiona...
What is the current status of trial NCT05863052?
This trial is currently active not recruiting. The enrollment target is 72 participants. The study started on 2022-01-31. Estimated completion is 2027-12.
What conditions does trial NCT05863052 study?
This clinical trial studies the following conditions: Non-Small Cell Lung Cancer, Melanoma, Renal Cell Carcinoma, Metastatic Solid Tumor, Gastrointestinal Cancer.
What interventions are being tested in trial NCT05863052?
The interventions under investigation include: Immunotherapy (BIOLOGICAL).
Who is sponsoring clinical trial NCT05863052?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05863052 being conducted?
This trial has 6 study locations across Arizona, New Mexico, Oklahoma, South Dakota, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-Small Cell Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05863052's enrollment target sits among peer trials
72 284th of 454 higher than 170 of 454 other Non-Small Cell Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Non-Small Cell Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RECRUITING · Phase 3
-
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
RECRUITING · Phase 1
-
Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
RECRUITING · Phase 1
-
A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
RECRUITING · Phase 1
-
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI